Among matched primary and metastatic cancer tissues, the loss of MKK4 in immunolabeling was observed in 11% of primary cancers, but in as many as 37% of distant metastases, indicating that MKK4 loss correlates with metastasis formation. Here, MAP2K4 is linked to cancer.